The role of stanniocalcin 2 in oral squamous cells carcinoma

杨舒雯; 王宇; 杨恭

doi:10.3969/j.issn.1007-3969.2015.04.005

您当前的位置：

首页 >

文章列表页 >

The role of stanniocalcin 2 in oral squamous cells carcinoma

更新时间：2025-12-31

- The role of stanniocalcin 2 in oral squamous cells carcinoma
- China Oncology Vol. 25, Issue 4, Pages: 269-274(2015)
- 作者机构：
  
  1. 复旦大学附属肿瘤医院头颈外科，复旦大学上海医学院肿瘤学系,上海,200032
  2. 复旦大学附属肿瘤医院肿瘤研究所，复旦大学上海医学院肿瘤学系,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2015.04.005
  CLC：
- Published Online：25 May 2015，
  
  Published：25 May 2015
- 稿件说明：
移动端阅览
杨舒雯,王宇,杨恭. 斯钙素2对口腔鳞癌细胞的作用及机制研究[J]. 中国癌症杂志, 2015, 25(4): 269-274.

杨舒雯, 王宇, 杨恭. The role of stanniocalcin 2 in oral squamous cells carcinoma[J]. China Oncology, 2015, 25(4): 269-274.
杨舒雯,王宇,杨恭. 斯钙素2对口腔鳞癌细胞的作用及机制研究[J]. 中国癌症杂志, 2015, 25(4): 269-274. DOI： 10.3969/j.issn.1007-3969.2015.04.005.

杨舒雯, 王宇, 杨恭. The role of stanniocalcin 2 in oral squamous cells carcinoma[J]. China Oncology, 2015, 25(4): 269-274. DOI： 10.3969/j.issn.1007-3969.2015.04.005.

摘要

背景与目的：口腔颌面部恶性肿瘤中约80%以上为口腔鳞状细胞癌(oral squamous cell carcinoma，OSCC)，虽过去的几十年诊断及治疗技术不断改进，其存活率却没有得到明显改善，5年生存率仍小于50%。该研究旨在探讨斯钙素2(stanniocalcin 2，STC2)对口腔鳞癌细胞KB的增殖、凋亡及侵袭迁移的影响。方法：构建STC2的RNA干扰载体，将其转染KB细胞使STC2基因沉默后，采用CCK8实验检测STC2对KB细胞增殖的影响，通过APC Annexin V/7-AAD染色、流式细胞术检测细胞凋亡情况，分析STC2对细胞凋亡的影响。细胞划痕和细胞小室(Transwell)试验分析比较STC2基因沉默后对口腔鳞癌细胞侵袭和迁移的差异。最后用蛋白[质]印迹法(Western blot)检测凋亡、转移相关蛋白。结果：成功构建KB细胞STC2敲除细胞系，CCK8增殖实验结果显示，STC2沉默后，细胞增殖被明显抑制，其生长速度低于对照组(P0.001)。在顺铂诱导细胞凋亡过程中，STC2沉默后KB细胞凋亡一定程度被促进。与KB细胞相比，STC2沉默后的细胞迁移和侵袭性明显减弱。Western blot检测发现，沉默STC2后Bcl-2、促细胞迁移和侵袭蛋白Caveolin-1和β-catenin表达下调，bax表达上升。结论：STC2可能参与调控口腔鳞癌细胞KB的增殖凋亡，促进KB细胞的侵袭转移能力，同时一定程度上减弱KB对化疗药物顺铂的敏感性。

Abstract

Background and purpose: About 80% patients with oral and maxillofacial malignant tumor are oral squamous cell carcinoma (OSCC). OSCC is one of the most common cancers in the world with less than 50% survival rate over 5 years. This experiment aimed to explore the effect of stanniocalcin 2 (STC2) on apoptosis

proliferation

migration and invasion of OSCC cell. Methods: RNA interference (RNAi) vector pLKO.1-shSTC2 was constructed and transfected into KB cells. Cell proliferation and cell apoptosis were then assessed by CCK8

APC Annexin V/7-AAD and flow cytometry. Differences of migration and invasion between KB scr and KB STC2i were examined by cell scratch and transwell tests. Finally

this study detected the apoptosis-associated proteins and metastasis-associated proteins by Western blot. Results: STC2 down-regulation plasmid was constructed and transfected into KB cells. CCK8 proliferation assay revealed that the STC2 down-regulation inhibited KB cells proliferation. By treating with cisplatin

this study found that STC2 silence could facilitate cell apoptosis significantly. With the knock down of STC2 gene

the expressions of Bcl-2

Caveolin-1 and β-catenin were decreased but the expression of bax was obviously increased. Conclusion: These data suggest that STC2 may be involved in the apoptosis

proliferation

migration and invasion of OSCC KB cells. Simultaneously

it can significantly weaken the sensitivity of KB cells to chemotherapeutic drug cisplatin.

关键词

Keywords

references

Views

1808

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanistic study on PLK4 regulation of invasion, proliferation and apoptosis in oral squamous cell carcinoma

Mechanism of circular RNA hsa_circ_0012779 expression in nasopharyngeal carcinoma and its influence on cell biological behavior

Effect of tRF-Pro-CGG on the biological behavior of mouse pancreatic cancer cells and its molecular mechanism

Effects of NOL8 on cell proliferation, migration and invasion of oral squamous cell carcinoma

LINC02163 targeting miR-338-3p affects proliferation, invasion and migration of breast cancer cells

Related Author

Huan QIN

Jie WANG

Jie YANG

Yingjie HUA

Huijuan QU

Honghai JI

Pingchuan ZHANG

Mingyu DU

Related Institution

Department of Stomatology, Affiliated Hospital of Shandong Second Medical University

Shouguang Stomatological Hospital

School of Stomatology, Shandong Second Medical University

Department of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research

The Fourth School of Clinical Medicine, Nanjing Medical University

AI问答

⁰